Abstract Details
|
Georges Naasan, MD
(Mount Sinai)
PRESENTER |
Dr. Naasan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genentech . |
| Sarosh R. Irani, MD, PhD, FRCP, FEAN (Mayo Clinic) | Dr. Irani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB, Cerebral therapeutics, Roche and Janssen. Dr. Irani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for LLPs. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. |
| Brianne Bettcher | No disclosure on file |
| Michael D. Geschwind, MD, PhD, FAAN (UCSF) | Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc.. |
| Jeffrey M. Gelfand, MD, MAS, FAAN (University of California, San Francisco) | Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant and Expert, Vaccine Injury Compensation Program with United States Health and Human Services and Department of Justice. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to AAN interests or activities. |
| Nicholas Boulis | Nicholas Boulis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Nicholas Boulis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Nicholas Boulis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sio Gene Therapy. Nicholas Boulis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Nicholas Boulis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BlueRock. Nicholas Boulis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CODA Bio. Nicholas Boulis has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Gibbs Attorneys. Nicholas Boulis has received stock or an ownership interest from Curative. Nicholas Boulis has received stock or an ownership interest from Remotor. The institution of Nicholas Boulis has received research support from NIH. Nicholas Boulis has received intellectual property interests from a discovery or technology relating to health care. Nicholas Boulis has received intellectual property interests from a discovery or technology relating to health care. Nicholas Boulis has received intellectual property interests from a discovery or technology relating to health care. Nicholas Boulis has received intellectual property interests from a discovery or technology relating to health care. Nicholas Boulis has received publishing royalties from a publication relating to health care. |